Daratumumab treatment for therapy-refractory anti-CASPR2 encephalitis
暂无分享,去创建一个
C. Meisel | A. Meisel | H. Prüss | F. Scheibe | S. Reincke | T. Alexander | Martin Köhnlein | L. Ostendorf | A. Brünneck | S. M. Reincke | Ann-Christin von Brünneck
[1] H. Prüss,et al. Affinities of human NMDA receptor autoantibodies: implications for disease mechanisms and clinical diagnostics , 2018, Journal of Neurology.
[2] Anne-Kathrin Kienzler,et al. The clinical features, underlying immunology, and treatment of autoantibody‐mediated movement disorders , 2018, Movement disorders : official journal of the Movement Disorder Society.
[3] K. Chu,et al. Bortezomib treatment for severe refractory anti‐NMDA receptor encephalitis , 2018, Annals of clinical and translational neurology.
[4] M. Farrell,et al. Durable treatment response of relapsing CNS plasmacytoma using intrathecal chemotherapy, radiotherapy, and Daratumumab , 2018, Clinical case reports.
[5] F. Shi,et al. Safety and Efficacy of Bortezomib in Patients With Highly Relapsing Neuromyelitis Optica Spectrum Disorder , 2017, JAMA neurology.
[6] F. Hiepe,et al. Bortezomib for treatment of therapy-refractory anti-NMDA receptor encephalitis , 2017, Neurology.
[7] A. Palumbo,et al. Phase 1/2 study of daratumumab, lenalidomide, and dexamethasone for relapsed multiple myeloma. , 2016, Blood.
[8] A. Palumbo,et al. Daratumumab, Bortezomib, and Dexamethasone for Multiple Myeloma. , 2016, The New England journal of medicine.
[9] J. Dalmau,et al. The clinical spectrum of Caspr2 antibody–associated disease , 2016, Neurology.
[10] Bie M. P. Verbist,et al. Daratumumab depletes CD38+ immune regulatory cells, promotes T-cell expansion, and skews T-cell repertoire in multiple myeloma. , 2016, Blood.
[11] Andreas Radbruch,et al. The proteasome inhibitior bortezomib depletes plasma cells and ameliorates clinical manifestations of refractory systemic lupus erythematosus , 2015, Annals of the rheumatic diseases.
[12] Andreas Radbruch,et al. Foxp3+ Helios+ regulatory T cells are expanded in active systemic lupus erythematosus , 2012, Annals of the rheumatic diseases.